Anhui Anke BioTech Group (300009) — Free Cash Flow Generation Index
Anhui Anke BioTech Group (300009) has a Free Cash Flow Generation Index of 0.91x as of September 2025. Free cash flow of CN¥218.88 Million represents 1% of operating cash flow (CN¥240.51 Million). Explore Anhui Anke BioTech Group (300009) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Anhui Anke BioTech Group Free Cash Flow Generation Index (2006–2025)
Historical FCF Generation Index trend for Anhui Anke BioTech Group across 20 annual periods. For the full cash flow conversion analysis, see Anhui Anke BioTech Group operating cash flow efficiency.
Annual Free Cash Flow Generation for Anhui Anke BioTech Group (2006–2025)
Year-by-year Free Cash Flow Generation Index for Anhui Anke BioTech Group. Check Anhui Anke BioTech Group (300009) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.85x | CN¥736.33 Million | CN¥863.22 Million | CN¥126.89 Million | ▲ +2.9% |
| 2024 | 0.83x | CN¥568.15 Million | CN¥685.37 Million | CN¥117.22 Million | ▲ +4.3% |
| 2023 | 0.80x | CN¥757.64 Million | CN¥952.97 Million | CN¥195.34 Million | ▲ +147.4% |
| 2022 | 0.32x | CN¥224.64 Million | CN¥698.98 Million | CN¥474.34 Million | ▼ -58.7% |
| 2021 | 0.78x | CN¥460.94 Million | CN¥592.17 Million | CN¥131.23 Million | ▲ +10.9% |
| 2020 | 0.70x | CN¥326.27 Million | CN¥464.80 Million | CN¥138.52 Million | ▲ +90.1% |
| 2019 | 0.37x | CN¥109.15 Million | CN¥295.63 Million | CN¥186.48 Million | ▲ +43.9% |
| 2018 | 0.26x | CN¥73.77 Million | CN¥287.49 Million | CN¥213.72 Million | ▼ -51.6% |
| 2017 | 0.53x | CN¥148.85 Million | CN¥280.63 Million | CN¥131.78 Million | ▼ -27.5% |
| 2016 | 0.73x | CN¥188.83 Million | CN¥258.01 Million | CN¥69.18 Million | ▲ +6.3% |
| 2015 | 0.69x | CN¥81.78 Million | CN¥118.73 Million | CN¥36.95 Million | ▲ +262.6% |
| 2014 | 0.19x | CN¥20.65 Million | CN¥108.68 Million | CN¥88.04 Million | ▼ -53.2% |
| 2013 | 0.41x | CN¥21.58 Million | CN¥53.21 Million | CN¥31.64 Million | ▲ +488.2% |
| 2012 | -0.10x | CN¥-5.62 Million | CN¥53.80 Million | CN¥59.42 Million | ▲ +99.0% |
| 2011 | -10.49x | CN¥-75.36 Million | CN¥7.18 Million | CN¥82.54 Million | ▼ -1473.2% |
| 2010 | 0.76x | CN¥36.25 Million | CN¥47.43 Million | CN¥11.18 Million | ▲ +13.1% |
| 2009 | 0.68x | CN¥26.14 Million | CN¥38.67 Million | CN¥12.54 Million | ▼ -9.8% |
| 2008 | 0.75x | CN¥19.52 Million | CN¥26.04 Million | CN¥6.52 Million | ▲ +2.1% |
| 2007 | 0.73x | CN¥25.77 Million | CN¥35.10 Million | CN¥9.32 Million | ▼ -19.6% |
| 2006 | 0.91x | CN¥27.09 Million | CN¥29.66 Million | CN¥2.57 Million | — |